US5693341A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Affinity bound collagen matrices for the delivery of biologically active agents
Assignee: Angiotech Pharmaceuticals Inc
•
Filing: 1995-03-16
•
Granted: 1997-12-02
•
Expires: 2015-03-16
Abstract
Abstract Affinity bound collagen matrices for the delivery of biologically active agents, and methods for preparing such matrices, are disclosed. A preferred method for preparing the matrices of the invention comprises mixing a binding ligand and an active agent together, allowing the resulting binding ligand-active agent mixture to form an affinity bound complex, then combining the resulting affinity bound complex with collagen to form a matrix. Particular affinity bound matrices comprising collagen, heparin, and an active agent are also disclosed, as well as methods for using the matrices of the invention for delivery of biologically active agents.
Inventors
- 👤 Jacqueline A. Schroeder
- 👤 Hanne Bentz
- 👤 Trudy D. Estridge
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-24 22:03
CPC Classifications
A; A61; A61K; A61K47/00; A61K47/50; A61K47/51; A61K47/62; A61K47/64; A61K47/6435
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
158 words
A method of preparing an affinity bound matrix comprising collagen, a polyanionic carbohydrate, and a positively charged biologically active protein, said method comprising, in order, the steps of: (i) mixing the polyanionic carbohydrate with the positively charged biologically active protein in the absence of collagen to prepare a polyanionic carbohydrate-positively charged biologically active protein mixture; (ii) maintaining said polyanionic carbohydrate-positively charged biologically active protein mixture for a sufficient length of time in the absence of collagen under conditions suitable to form a polyanionic carbohydrate-positively charged biologically active protein affinity bound complex; and (iii) admixing said polyanionic carbohydrate-positively charged biologically active protein affinity bound complex with collagen under conditions suitable to form said affinity bound matrix; wherein said positively charged biologically active protein is more stable in said affinity bound matrix than an equivalent affinity bound matrix formed without a first step of mixing said polyanionic carbohydrate with said positively charged biologically active protein in the absence of collagen.
Claim 2
Independent Claim
158 words
A method of preparing an affinity bound matrix comprising collagen, a polyanionic carbohydrate, and a positively charged biologically active protein, said method comprising, in order, the steps of: (i) mixing the polyanionic carbohydrate with the positively charged biologically active protein in the absence of collagen to prepare a polyanionic carbohydrate-positively charged biologically active protein mixture; (ii) maintaining said polyanionic carbohydrate-positively charged biologically active protein mixture for a sufficient length of time in the absence of collagen under conditions suitable to form a polyanionic carbohydrate-positively charged biologically active protein affinity bound complex; and (iii) admixing said polyanionic carbohydrate-positively charged biologically active protein affinity bound complex with collagen under conditions suitable to form said affinity bound matrix; wherein said positively charged biologically active protein is more stable in said affinity bound matrix than an equivalent affinity bound matrix formed without a first step of mixing said polyanionic carbohydrate with said positively charged biologically active protein in the absence of collagen.
Claim 3
Dependent Claim
27 words
The method of claim 1, wherein the polyanionic carbohydrate is selected from the group consisting of: heparin, heparin-like compounds, heparin-containing compounds, and compounds having heparin-like binding affinities.
Claim 4
Dependent Claim
11 words
The method of claim 2, wherein the polyanionic carbohydrate is heparin.
Claim 5
Independent Claim
148 words
A method of preparing an affinity bound matrix comprising collagen, heparin, and a positively charged biologically active protein, said method comprising, in order, the steps of: (i) mixing the heparin with the positively charged biologically active protein in the absence of collagen to prepare a heparin-positively charged biologically active protein mixture; and (ii) maintaining said heparin-positively charged biologically active protein mixture for a sufficient length of time in the absence of collagen under conditions suitable to form a heparin-positively charged biologically active protein affinity bound complex; and (iii) admixing said heparin-positively charged biologically active protein affinity bound complex with collagen under conditions suitable to form said affinity bound matrix; wherein said biologically active protein is more stable in said affinity bound matrix than an equivalent affinity bound matrix formed without a first step of mixing said polyanionic carbohydrate with said biologically active protein in the absence of collagen.
Claim 6
Independent Claim
148 words
A method of preparing an affinity bound matrix comprising collagen, heparin, and a positively charged biologically active protein, said method comprising, in order, the steps of: (i) mixing the heparin with the positively charged biologically active protein in the absence of collagen to prepare a heparin-positively charged biologically active protein mixture; and (ii) maintaining said heparin-positively charged biologically active protein mixture for a sufficient length of time in the absence of collagen under conditions suitable to form a heparin-positively charged biologically active protein affinity bound complex; and (iii) admixing said heparin-positively charged biologically active protein affinity bound complex with collagen under conditions suitable to form said affinity bound matrix; wherein said biologically active protein is more stable in said affinity bound matrix than an equivalent affinity bound matrix formed without a first step of mixing said polyanionic carbohydrate with said biologically active protein in the absence of collagen.
Claim 7
Dependent Claim
22 words
The method of claim 1 or 4, wherein the positively charged biologically active protein is in the transforming growth factor supergene family.
Claim 8
Dependent Claim
17 words
The method of claim 5, wherein the positively charged biologically active protein is transforming growth factor beta.
Claim 9
Dependent Claim
36 words
The method of claim 4, wherein the heparin-positively charged biologically active protein mixture is incubated at a temperature within the range of about 0° C. to about 8° C. for a minimum of about 24 hours.
Claim 10
Dependent Claim
37 words
The method of claim 4, wherein the heparin and the positively charged biologically active protein are present in the affinity bound matrix in a weight ratio of between about 0.01:1 to about 5:1 heparin to active agent.
References Cited (Backward Citations)
US4760131A
Cited
US5100668A
Cited
US4950483A
Cited
US5024841A
Cited
US5110604A
Cited
US5219576A
Cited
US5206023A
Cited
US5368858A
Cited
US5270300A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 2000-12-01 | 2001-06-02 | 2001-12-02 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 2004-12-01 | 2005-06-02 | 2005-12-02 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 2008-12-01 | 2009-06-02 | 2009-12-02 | $7700.00 | Window Closed / Lapsed |